PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Nausea

Drugs in development · updated 30 October 2026

Nausea: drugs in development

As of 30 October 2026 there are 19 active clinical trials (recruiting or ongoing, phases I–III) on 15 drugs for nausea. 4 are experimental, that is not yet approved in the United States.

19Active trials
4Experimental drugs
2Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Experimental drugs

Not yet approved by the US FDA for any indication.

DrugMost advanced phaseActive trialsReference trial
AntiemeticIII1NCT06314906
DomperidoneIII1NCT01696734
FosrolapitantII1NCT07692451
LY3537021II1NCT07169851

Sorted by most advanced phase and number of active trials.

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
DexamethasoneDexametasone, DextenzaIII4NCT07716228
OndansetronZuplenz®, Zofran Odt®II–III3NCT05418244
RimegepantBHV3000, Nurtec Odt®III3NCT04743141
FosaprepitantIvemend®II–III2NCT06382012
OlanzapineWeltruza®, Zyprexa Relprevv®III2NCT07208305
GemcitabineGemcitabin, GemzarIII1NCT06017284
MetoclopramideGimoti®, Metozolv Odt®III1NCT07208305
ThalidomideThalomid®, Thalidomide Lipomed®III1NCT06017284
TradipitantNereus®III1NCT07446439
Palonosetron hydrochloridePosfrea®, Aloxi®II2NCT06904235
MetforminRiomet Er®, Glumetza®I–II1NCT07129473

Sorted by most advanced phase and number of active trials.

All 15 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Specific forms

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D009325 “Nausea”.

ItalianoFrançaisDeutsch